Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-26

FDA Approved: SPIRONOLACTONE — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Accord Healthcare's generic spironolactone. This action confirms approval of modifications under the ANDA for the pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

SUPPL AP for SPIRONOLACTONE (SPIRONOLACTONE)